Michael F. Goldberg

Company: Boston Gene

Job title: Vice President - R&D

Seminars:

Integrated Immune Profiling of Peripheral Blood & Tumor Tissue for Rational Stratification of Patients in Immunotherapy Trials 2:35 pm

Identification of Immunological Signatures: Overlapping immunological signatures with putative treatment mechanisms of action (MOA) can significantly increase the probability of successful outcomes in immunotherapy trials Immune System Profiling: Profiling the immune system can identify a patient’s immune status, which may reveal resistance to various immune-based treatments. This information is crucial for tailoring personalized immunotherapy strategies…Read more

day: Day Three Track B